Andrew B Newman, MD
Pulmonary Disease · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Newman’s office at (650) 328-5222 to ask if they take your plan before you enroll.
California Medical Board record
Licence G32075 · Current
Licensed to practise in California · since 1976 · expires 2028-07-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$318,349
Medicare paid this office $318,349 for 318 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 266 | $98,405 | $111 |
| Long return visit (40+ min) | 229 | $88,120 | $164 |
| Diagnostic exam of nasal passages using an endoscope | 111 | $22,544 | $193 |
| Ultrasound scan of head and neck soft tissue | 186 | $22,274 | $116 |
| Ultrasound of heart, follow-up | 186 | $19,764 | $103 |
See all 14 services
| Return visit (30+ min) | 266 | $98,405 | $111 |
| Long return visit (40+ min) | 229 | $88,120 | $164 |
| Diagnostic exam of nasal passages using an endoscope | 111 | $22,544 | $193 |
| Ultrasound scan of head and neck soft tissue | 186 | $22,274 | $116 |
| Ultrasound of heart, follow-up | 186 | $19,764 | $103 |
| Test to examine how well the lungs exchange gases | 203 | $12,497 | $60 |
| Test to determine lung volumes using sensors | 203 | $12,168 | $59 |
| Ultrasound scan of chest | 185 | $10,700 | $56 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 203 | $8,337 | $40 |
| New patient visit (60+ min) | 30 | $6,038 | $201 |
| Test to measure expiratory airflow and volume | 135 | $5,156 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 185 | $4,956 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 186 | $4,814 | $25 |
| Inhalation treatment for airway obstruction or sputum production | 202 | $1,756 | $9 |
Who their Medicare patients are
318 Original Medicare patients in 2024. Average age 78 · Women 66% · Health risk score 1.20. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 64% · COPD 49% · Coronary heart disease 32% · Cancer 20% · Atrial fibrillation 19% · Chronic kidney disease 17% · Diabetes 16% · Depression 15% · Heart failure 13% · Stroke 8% · Dementia 4%.
The office billed $918,722, Medicare allowed $417,541 and paid $318,349; for 3,564 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 318 | 3,564 | 78 | 1.20 | $918,722 | $318,349 |
| 2023 | 330 | 3,694 | 78 | 1.20 | $955,282 | $328,891 |
| 2022 | 342 | 3,747 | 77 | 1.25 | $967,144 | $334,931 |
| 2021 | 355 | 3,898 | 77 | 1.20 | $1,053,814 | $386,811 |
| 2020 | 328 | 2,629 | 77 | 1.24 | $692,510 | $235,717 |
| 2019 | 342 | 4,956 | 77 | 1.26 | $1,132,906 | $376,317 |
| 2018 | 330 | 5,013 | 77 | 1.28 | $1,157,789 | $410,386 |
| 2017 | 329 | 4,553 | 76 | 1.26 | $500,349 | $374,127 |
| 2016 | 333 | 5,017 | 76 | 1.32 | $575,408 | $400,623 |
| 2015 | 321 | 5,005 | 76 | 1.33 | $564,727 | $365,939 |
| 2014 | 327 | 4,771 | 76 | 1.28 | $543,209 | $344,101 |
| 2013 | 295 | 3,927 | 76 | 1.26 | $419,949 | $280,982 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 277 | $109,468 | $109 |
| Long return visit (40+ min) | 237 | $87,879 | $159 |
| Diagnostic exam of nasal passages using an endoscope | 131 | $26,130 | $195 |
| Ultrasound scan of head and neck soft tissue | 162 | $19,376 | $117 |
| Ultrasound of heart, follow-up | 161 | $16,868 | $102 |
| Test to examine how well the lungs exchange gases | 225 | $13,606 | $60 |
| Test to determine lung volumes using sensors | 224 | $12,801 | $56 |
| Ultrasound scan of chest | 162 | $9,374 | $56 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 226 | $9,060 | $40 |
| New patient visit (60+ min) | 34 | $6,603 | $194 |
| Test to measure expiratory airflow and volume | 140 | $5,392 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 161 | $4,285 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 161 | $4,127 | $25 |
| Inhalation treatment for airway obstruction or sputum production | 226 | $2,220 | $10 |
2022: 14 services
| Return visit (30+ min) | 302 | $114,000 | $111 |
| Long return visit (40+ min) | 243 | $88,215 | $157 |
| Diagnostic exam of nasal passages using an endoscope | 132 | $27,980 | $194 |
| Ultrasound scan of head and neck soft tissue | 159 | $19,463 | $117 |
| Ultrasound of heart, follow-up | 160 | $17,088 | $102 |
| Test to examine how well the lungs exchange gases | 210 | $13,325 | $61 |
| Test to determine lung volumes using sensors | 201 | $11,650 | $56 |
| Ultrasound scan of chest | 161 | $9,629 | $57 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 210 | $8,552 | $39 |
| Test to measure expiratory airflow and volume | 162 | $6,851 | $26 |
| New patient visit (60+ min) | 25 | $4,895 | $196 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 160 | $4,393 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 160 | $4,222 | $25 |
| Inhalation treatment for airway obstruction or sputum production | 210 | $2,564 | $12 |
2021: 14 services
| Long return visit (40+ min) | 268 | $143,104 | $167 |
| Return visit (30+ min) | 294 | $122,084 | $112 |
| Diagnostic exam of nasal passages using an endoscope | 80 | $17,196 | $205 |
| Ultrasound of heart, follow-up | 147 | $17,000 | $107 |
| Ultrasound scan of head and neck soft tissue | 125 | $16,296 | $123 |
| Test to examine how well the lungs exchange gases | 202 | $13,729 | $64 |
| Ultrasound scan of chest | 149 | $11,022 | $68 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 202 | $10,569 | $49 |
| Test to determine lung volumes using gas dilution or washout | 195 | $9,613 | $46 |
| Test to measure expiratory airflow and volume | 118 | $5,226 | $30 |
| New patient visit (60+ min) | 26 | $5,213 | $200 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 147 | $4,475 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 147 | $4,310 | $27 |
| Inhalation treatment for airway obstruction or sputum production | 202 | $3,299 | $15 |
2020: 15 services
| Return visit (30+ min) | 275 | $132,846 | $99 |
| Long return visit (40+ min) | 150 | $52,398 | $135 |
| Ultrasound of heart, follow-up | 77 | $8,483 | $106 |
| Diagnostic exam of nasal passages using an endoscope | 34 | $7,286 | $202 |
| Ultrasound scan of chest | 78 | $6,668 | $82 |
| Test to measure expiratory airflow and volume | 141 | $6,087 | $33 |
| New patient visit (60+ min) | 34 | $5,697 | $168 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 41 | $2,522 | $62 |
| Test to examine how well the lungs exchange gases | 41 | $2,482 | $61 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 77 | $2,271 | $28 |
| Test to measure the level of nitric oxide gas | 107 | $2,239 | $18 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 77 | $2,187 | $27 |
| Test to determine lung volumes using gas dilution or washout | 41 | $1,877 | $46 |
| Short return visit (20+ min) | 14 | $1,811 | $55 |
| Inhalation treatment for airway obstruction or sputum production | 41 | $796 | $19 |
2019: 14 services
| Return visit (30+ min) | 290 | $105,690 | $96 |
| Long return visit (40+ min) | 226 | $94,750 | $136 |
| Diagnostic exam of nasal passages using an endoscope | 190 | $42,131 | $208 |
| Ultrasound of heart, follow-up | 201 | $20,879 | $103 |
| Ultrasound scan of chest | 203 | $18,843 | $92 |
| Test to measure expiratory airflow and volume | 225 | $18,073 | $35 |
| Test to measure the level of nitric oxide gas | 260 | $14,239 | $21 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 211 | $13,688 | $63 |
| Test to examine how well the lungs exchange gases | 212 | $12,863 | $58 |
| Test to determine lung volumes using gas dilution or washout | 212 | $9,926 | $45 |
| New patient visit (60+ min) | 36 | $6,633 | $184 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 201 | $5,690 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 201 | $5,479 | $27 |
| Inhalation treatment for airway obstruction or sputum production | 212 | $4,290 | $20 |
2018: 14 services
| Return visit (30+ min) | 296 | $118,367 | $100 |
| Long return visit (40+ min) | 224 | $99,371 | $145 |
| Diagnostic exam of nasal passages using an endoscope | 189 | $47,682 | $229 |
| Ultrasound of heart, follow-up | 200 | $24,346 | $117 |
| Test to measure expiratory airflow and volume | 210 | $20,897 | $38 |
| Ultrasound scan of chest | 202 | $20,541 | $98 |
| Test to measure the level of nitric oxide gas | 241 | $13,904 | $22 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 196 | $13,866 | $67 |
| Test to examine how well the lungs exchange gases | 202 | $12,997 | $61 |
| Test to determine lung volumes using gas dilution or washout | 202 | $10,275 | $48 |
| New patient visit (60+ min) | 36 | $6,984 | $194 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 200 | $6,296 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 199 | $6,009 | $29 |
| Inhalation treatment for airway obstruction or sputum production | 198 | $4,446 | $21 |
2017: 14 services
| Return visit (30+ min) | 309 | $108,256 | $92 |
| Long return visit (40+ min) | 238 | $90,448 | $132 |
| Diagnostic exam of nasal passages using an endoscope | 194 | $42,367 | $212 |
| Ultrasound of heart, follow-up | 219 | $28,945 | $129 |
| Ultrasound scan of chest | 219 | $20,029 | $89 |
| Test to measure expiratory airflow and volume | 209 | $15,761 | $34 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 228 | $14,573 | $62 |
| Test to examine how well the lungs exchange gases | 228 | $13,179 | $56 |
| Test to determine lung volumes using gas dilution or washout | 226 | $9,879 | $43 |
| New patient visit (60+ min) | 39 | $7,383 | $189 |
| Test to measure the level of nitric oxide gas | 177 | $6,682 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 219 | $6,254 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 219 | $6,039 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $3,345 | $93 |
2016: 14 services
| Return visit (30+ min) | 300 | $120,039 | $93 |
| Long return visit (40+ min) | 254 | $90,415 | $131 |
| Diagnostic exam of nasal passages using an endoscope | 206 | $46,105 | $212 |
| Ultrasound of heart, follow-up | 222 | $29,032 | $128 |
| Ultrasound scan of chest | 222 | $20,315 | $89 |
| Test to measure expiratory airflow and volume | 213 | $20,064 | $35 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 231 | $14,634 | $63 |
| Test to examine how well the lungs exchange gases | 231 | $13,179 | $56 |
| Test to measure the level of nitric oxide gas | 205 | $10,237 | $20 |
| Test to determine lung volumes using gas dilution or washout | 229 | $9,879 | $43 |
| New patient visit (60+ min) | 42 | $7,573 | $180 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 222 | $6,302 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 222 | $6,063 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $5,648 | $93 |
2015: 15 services
| Return visit (30+ min) | 297 | $110,234 | $87 |
| Long return visit (40+ min) | 239 | $83,318 | $125 |
| Diagnostic exam of nasal passages using an endoscope | 192 | $40,105 | $197 |
| Ultrasound of heart, follow-up | 205 | $25,187 | $120 |
| Test to measure expiratory airflow and volume | 230 | $19,659 | $33 |
| Ultrasound scan of chest | 209 | $17,940 | $83 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 224 | $13,861 | $58 |
| Test to examine how well the lungs exchange gases | 224 | $12,501 | $53 |
| Test to measure the level of nitric oxide gas | 238 | $11,764 | $19 |
| Test to determine lung volumes using gas dilution or washout | 223 | $9,411 | $40 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 205 | $5,483 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 205 | $5,300 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $5,051 | $87 |
| New patient visit (60+ min) | 31 | $4,959 | $160 |
| Short return visit (20+ min) | 11 | $820 | $63 |
2014: 14 services
| Return visit (30+ min) | 306 | $110,528 | $88 |
| Long return visit (40+ min) | 227 | $74,215 | $125 |
| Diagnostic exam of nasal passages using an endoscope | 163 | $34,190 | $199 |
| Ultrasound of heart, follow-up | 188 | $22,516 | $117 |
| Test to measure expiratory airflow and volume | 230 | $21,775 | $34 |
| Ultrasound scan of chest | 194 | $17,041 | $85 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 206 | $12,469 | $59 |
| Test to measure the level of nitric oxide gas | 215 | $10,348 | $19 |
| Test to determine lung volumes using gas dilution or washout | 210 | $8,638 | $40 |
| Test to examine how well the lungs exchange gases | 210 | $8,299 | $38 |
| New patient visit (60+ min) | 36 | $6,252 | $174 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 188 | $5,675 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 188 | $4,862 | $25 |
| Short return visit (20+ min) | 11 | $1,337 | $64 |
2013: 14 services
| Return visit (30+ min) | 264 | $91,477 | $92 |
| Long return visit (40+ min) | 199 | $48,802 | $125 |
| Diagnostic exam of nasal passages using an endoscope | 157 | $33,573 | $206 |
| Test to measure expiratory airflow and volume | 212 | $21,204 | $35 |
| Ultrasound of heart, follow-up | 153 | $15,138 | $96 |
| Ultrasound scan of chest | 170 | $15,049 | $85 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 177 | $11,335 | $60 |
| Test to examine how well the lungs exchange gases | 177 | $10,241 | $55 |
| Test to measure the level of nitric oxide gas | 197 | $9,978 | $21 |
| Test to determine lung volumes using gas dilution or washout | 177 | $8,288 | $45 |
| New patient visit (60+ min) | 28 | $4,969 | $177 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 153 | $3,525 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 153 | $3,035 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,996 | $86 |
Drugs they prescribed that Part D paid
$683,334
Pharmacies billed $683,334 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,046 generic and fewer than 11 brand-name prescriptions · $683,334 in drug cost · 355 antibiotic prescriptions to 132 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 143 | $157,270 | $1,100 |
| Breo Ellipta | 107 | $94,980 | $888 |
| Breztri Aerosphere | 62 | $67,321 | $1,086 |
| Stiolto Respimat | 65 | $58,222 | $896 |
| Spiriva Respimat | 44 | $49,139 | $1,117 |
See all 35 drugs
| Trelegy Ellipta | 143 | $157,270 | $1,100 |
| Breo Ellipta | 107 | $94,980 | $888 |
| Breztri Aerosphere | 62 | $67,321 | $1,086 |
| Stiolto Respimat | 65 | $58,222 | $896 |
| Spiriva Respimat | 44 | $49,139 | $1,117 |
| Dulera | 62 | $32,476 | $524 |
| Anoro Ellipta | 32 | $28,922 | $904 |
| Symbicort | 59 | $25,707 | $436 |
| Arnuity Ellipta | 31 | $19,019 | $614 |
| Fluticasone Propionate Hfa | 20 | $14,688 | $734 |
| Qvar Redihaler | 20 | $12,583 | $629 |
| Pulmicort Flexhaler | 27 | $12,217 | $452 |
| Incruse Ellipta | 12 | $11,624 | $969 |
| Montelukast | 325 | $5,125 | $16 |
| Theo-24 | 11 | $3,895 | $354 |
| Azithromycin | 157 | $3,098 | $20 |
| Zafirlukast | 18 | $2,310 | $128 |
| Synthroid | 12 | $1,956 | $163 |
| Breyna | 13 | $1,673 | $129 |
| Budesonide-Formoterol | 14 | $1,498 | $107 |
| Paxlovid | 48 | $1,429 | $30 |
| Amoxicillin-Clavulanate Potass | 70 | $1,027 | $15 |
| Doxycycline Hyclate | 46 | $848 | $18 |
| Azelastine | 17 | $766 | $45 |
| Albuterol Sulfate Hfa | 16 | $691 | $43 |
| Ipratropium | 19 | $675 | $36 |
| Pantoprazole | 16 | $386 | $24 |
| Fluconazole | 12 | $322 | $27 |
| Zolpidem | 24 | $230 | $10 |
| Escitalopram | 20 | $163 | $8 |
| Ciprofloxacin | 25 | $154 | $6 |
| Atorvastatin | 13 | $113 | $9 |
| Alprazolam | 15 | $79 | $5 |
| Prednisone | 12 | $72 | $6 |
| Amlodipine Besylate | 16 | $62 | $4 |
Year by year
| 2024 | 1,908 | 285 | None | None | $683,334 |
| 2023 | 2,003 | 283 | None | 41% | $763,282 |
| 2022 | 2,068 | 283 | 1% (15) | 44% | $812,793 |
| 2021 | 2,154 | 287 | 1% (21) | None | $831,710 |
| 2020 | 2,398 | 277 | None | 47% | $844,363 |
| 2019 | 2,034 | 263 | 1% (21) | None | $614,971 |
| 2018 | 2,153 | 258 | 1% (23) | 39% | $593,804 |
| 2017 | 2,136 | 273 | None | 40% | $533,391 |
| 2016 | 2,284 | 252 | 1% (18) | 45% | $465,438 |
| 2015 | 2,309 | 239 | 1% (28) | None | $458,736 |
| 2014 | 2,153 | 235 | 2% (40) | None | $444,076 |
| 2013 | 2,317 | 256 | 3% (74) | 48% | $413,636 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Trelegy Ellipta | 127 | $154,136 | $1,214 |
| Breo Ellipta | 97 | $94,326 | $972 |
| Symbicort | 107 | $71,527 | $668 |
| Stiolto Respimat | 66 | $66,190 | $1,003 |
| Spiriva Respimat | 61 | $61,557 | $1,009 |
| Breztri Aerosphere | 47 | $55,359 | $1,178 |
| Flovent Hfa | 58 | $48,208 | $831 |
| Anoro Ellipta | 41 | $32,071 | $782 |
| Dulera | 29 | $18,639 | $643 |
| Pulmicort Flexhaler | 21 | $11,573 | $551 |
| Qvar Redihaler | 15 | $8,349 | $557 |
| Budesonide-Formoterol | 16 | $7,076 | $442 |
| Montelukast | 341 | $5,932 | $17 |
| Clarithromycin Er | 25 | $5,561 | $222 |
| Omnaris | 12 | $3,726 | $311 |
| Azithromycin | 115 | $3,137 | $27 |
| Zafirlukast | 14 | $2,812 | $201 |
| Doxycycline Hyclate | 43 | $2,223 | $52 |
| Amoxicillin-Clavulanate Potass | 104 | $2,190 | $21 |
| Ipratropium | 22 | $1,936 | $88 |
| Synthroid | 16 | $1,774 | $111 |
| Azelastine | 24 | $1,647 | $69 |
| Paxlovid (Eua) | 90 | $948 | $11 |
| Zolpidem | 16 | $547 | $34 |
| Potassium Chloride | 14 | $333 | $24 |
| Esomeprazole Magnesium | 14 | $295 | $21 |
| Levothyroxine | 14 | $285 | $20 |
| Cefuroxime | 15 | $245 | $16 |
| Escitalopram | 17 | $179 | $11 |
| Levofloxacin | 17 | $162 | $10 |
| Fluticasone Propionate | 17 | $160 | $9 |
| Ciprofloxacin | 22 | $141 | $6 |
| Alprazolam | 14 | $138 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $127 | $9 |
| Prednisone | 12 | $86 | $7 |
| Alendronate | 12 | $85 | $7 |
| Amlodipine Besylate | 17 | $68 | $4 |
| Atorvastatin | 12 | $60 | $5 |
2022: 36 drugs
| Trelegy Ellipta | 131 | $148,628 | $1,135 |
| Symbicort | 157 | $102,638 | $654 |
| Breo Ellipta | 81 | $86,263 | $1,065 |
| Stiolto Respimat | 80 | $75,358 | $942 |
| Flovent Hfa | 77 | $71,654 | $931 |
| Spiriva Respimat | 61 | $65,304 | $1,071 |
| Anoro Ellipta | 42 | $36,069 | $859 |
| Breztri Aerosphere | 29 | $35,029 | $1,208 |
| Incruse Ellipta | 17 | $14,711 | $865 |
| Alvesco | 16 | $12,562 | $785 |
| Pulmicort Flexhaler | 20 | $12,153 | $608 |
| Dulera | 16 | $9,949 | $622 |
| Qvar Redihaler | 12 | $7,838 | $653 |
| Clarithromycin Er | 31 | $7,549 | $244 |
| Montelukast | 354 | $6,941 | $20 |
| Azelastine-Fluticasone | 22 | $5,556 | $253 |
| Budesonide-Formoterol | 18 | $5,281 | $293 |
| Omnaris | 13 | $5,000 | $385 |
| Azelastine | 63 | $4,095 | $65 |
| Azithromycin | 124 | $3,304 | $27 |
| Zafirlukast | 14 | $3,093 | $221 |
| Doxycycline Hyclate | 49 | $2,032 | $41 |
| Synthroid | 15 | $1,739 | $116 |
| Amoxicillin-Clavulanate Potass | 58 | $1,725 | $30 |
| Albuterol Sulfate Hfa | 11 | $992 | $90 |
| Ciprofloxacin | 22 | $685 | $31 |
| Fluticasone Propionate | 24 | $596 | $25 |
| Paxlovid (Eua) | 53 | $546 | $10 |
| Pantoprazole | 19 | $485 | $26 |
| Zolpidem | 16 | $392 | $24 |
| Cefuroxime | 16 | $369 | $23 |
| Esomeprazole Magnesium | 17 | $358 | $21 |
| Prednisone | 22 | $222 | $10 |
| Atorvastatin | 15 | $189 | $13 |
| Levocetirizine Dihydrochloride | 13 | $28 | $2 |
| Hydrochlorothiazide | 11 | $26 | $2 |
2021: 36 drugs
| Trelegy Ellipta | 137 | $146,604 | $1,070 |
| Symbicort | 182 | $131,425 | $722 |
| Breo Ellipta | 100 | $86,225 | $862 |
| Stiolto Respimat | 64 | $58,067 | $907 |
| Flovent Hfa | 62 | $57,665 | $930 |
| Spiriva Respimat | 54 | $52,206 | $967 |
| Anoro Ellipta | 46 | $46,269 | $1,006 |
| Incruse Ellipta | 49 | $27,514 | $562 |
| Dulera | 29 | $16,890 | $582 |
| Budesonide-Formoterol | 34 | $11,272 | $332 |
| Pulmicort Flexhaler | 15 | $9,436 | $629 |
| Alvesco | 12 | $8,851 | $738 |
| Montelukast | 425 | $8,476 | $20 |
| Arnuity Ellipta | 14 | $7,169 | $512 |
| Clarithromycin Er | 31 | $5,648 | $182 |
| Azelastine | 68 | $5,578 | $82 |
| Zafirlukast | 18 | $3,898 | $217 |
| Azithromycin | 89 | $3,398 | $38 |
| Doxycycline Hyclate | 54 | $2,664 | $49 |
| Synthroid | 24 | $2,146 | $89 |
| Albuterol Sulfate Hfa | 26 | $2,050 | $79 |
| Amoxicillin-Clavulanate Potass | 59 | $1,928 | $33 |
| Ventolin Hfa | 19 | $1,571 | $83 |
| Ipratropium | 17 | $1,382 | $81 |
| Fluticasone Propionate | 20 | $655 | $33 |
| Ciprofloxacin | 22 | $598 | $27 |
| Esomeprazole Magnesium | 18 | $597 | $33 |
| Potassium Chloride | 13 | $557 | $43 |
| Cefuroxime | 13 | $441 | $34 |
| Pantoprazole | 14 | $359 | $26 |
| Prednisone | 32 | $304 | $9 |
| Zolpidem | 18 | $217 | $12 |
| Atorvastatin | 16 | $211 | $13 |
| Acetaminophen-Codeine | 14 | $156 | $11 |
| Lorazepam | 13 | $64 | $5 |
| Hydrochlorothiazide | 16 | $44 | $3 |
2020: 45 drugs
| Symbicort | 195 | $119,218 | $611 |
| Trelegy Ellipta | 96 | $95,428 | $994 |
| Breo Ellipta | 139 | $92,669 | $667 |
| Flovent Hfa | 73 | $56,417 | $773 |
| Spiriva Respimat | 78 | $53,891 | $691 |
| Anoro Ellipta | 43 | $40,510 | $942 |
| Stiolto Respimat | 47 | $40,307 | $858 |
| Incruse Ellipta | 48 | $31,226 | $651 |
| Dulera | 47 | $30,408 | $647 |
| Bevespi Aerosphere | 24 | $17,868 | $744 |
| Budesonide-Formoterol | 39 | $17,526 | $449 |
| Qvar Redihaler | 29 | $16,869 | $582 |
| Pulmicort Flexhaler | 22 | $14,644 | $666 |
| Spiriva | 14 | $14,195 | $1,014 |
| Tudorza Pressair | 22 | $11,348 | $516 |
| Arnuity Ellipta | 21 | $9,348 | $445 |
| Clarithromycin Er | 37 | $8,153 | $220 |
| Montelukast | 433 | $7,780 | $18 |
| Dymista | 12 | $5,331 | $444 |
| Azithromycin | 117 | $5,040 | $43 |
| Azelastine | 71 | $4,338 | $61 |
| Omnaris | 13 | $3,771 | $290 |
| Doxycycline Hyclate | 109 | $3,709 | $34 |
| Zafirlukast | 16 | $3,402 | $213 |
| Ipratropium | 35 | $2,868 | $82 |
| Synthroid | 18 | $2,343 | $130 |
| Levalbuterol Tartrate Hfa | 11 | $1,093 | $99 |
| Amoxicillin-Clavulanate Potass | 45 | $1,024 | $23 |
| Esomeprazole Magnesium | 23 | $1,009 | $44 |
| Albuterol Sulfate Hfa | 13 | $935 | $72 |
| Potassium Chloride | 19 | $931 | $49 |
| Hydroxychloroquine Sulfate | 14 | $778 | $56 |
| Pantoprazole | 20 | $702 | $35 |
| Cefuroxime | 14 | $667 | $48 |
| Fluticasone Propionate | 12 | $487 | $41 |
| Ciprofloxacin | 15 | $376 | $25 |
| Fluconazole | 16 | $263 | $16 |
| Prednisone | 18 | $256 | $14 |
| Atorvastatin | 14 | $197 | $14 |
| Zolpidem | 12 | $157 | $13 |
| Sulfamethoxazole-Trimethoprim | 21 | $95 | $5 |
| Losartan | 12 | $86 | $7 |
| Hydrochlorothiazide | 12 | $74 | $6 |
| Lorazepam | 11 | $62 | $6 |
| Levocetirizine Dihydrochloride | 13 | $44 | $3 |
2019: 33 drugs
| Symbicort | 184 | $103,459 | $562 |
| Breo Ellipta | 123 | $81,000 | $659 |
| Spiriva Respimat | 55 | $43,470 | $790 |
| Anoro Ellipta | 45 | $42,199 | $938 |
| Trelegy Ellipta | 45 | $40,502 | $900 |
| Flovent Hfa | 29 | $26,655 | $919 |
| Dulera | 41 | $26,234 | $640 |
| Stiolto Respimat | 31 | $24,991 | $806 |
| Spiriva | 27 | $19,185 | $711 |
| Incruse Ellipta | 29 | $14,962 | $516 |
| Combivent Respimat | 11 | $11,239 | $1,022 |
| Pulmicort Flexhaler | 21 | $10,756 | $512 |
| Montelukast | 373 | $7,736 | $21 |
| Clarithromycin Er | 33 | $7,085 | $215 |
| Arnuity Ellipta | 17 | $6,457 | $380 |
| Azelastine | 59 | $4,790 | $81 |
| Azithromycin | 151 | $4,299 | $28 |
| Zafirlukast | 20 | $3,781 | $189 |
| Doxycycline Hyclate | 73 | $3,236 | $44 |
| Amoxicillin-Clavulanate Potass | 102 | $2,364 | $23 |
| Synthroid | 13 | $1,647 | $127 |
| Esomeprazole Magnesium | 24 | $1,083 | $45 |
| Fluticasone Propionate | 16 | $1,018 | $64 |
| Potassium Chloride | 17 | $961 | $57 |
| Ciprofloxacin | 26 | $660 | $25 |
| Pantoprazole | 19 | $659 | $35 |
| Ipratropium | 17 | $614 | $36 |
| Cefuroxime | 14 | $462 | $33 |
| Zolpidem | 16 | $271 | $17 |
| Prednisone | 19 | $270 | $14 |
| Hydrocodone-Acetaminophen | 13 | $121 | $9 |
| Levocetirizine Dihydrochloride | 12 | $42 | $4 |
| Lorazepam | 14 | $28 | $2 |
2018: 46 drugs
| Symbicort | 184 | $94,632 | $514 |
| Breo Ellipta | 122 | $77,237 | $633 |
| Flovent Hfa | 48 | $38,746 | $807 |
| Anoro Ellipta | 27 | $26,550 | $983 |
| Incruse Ellipta | 46 | $21,113 | $459 |
| Spiriva Respimat | 29 | $20,716 | $714 |
| Dulera | 28 | $19,111 | $683 |
| Advair Diskus | 25 | $17,897 | $716 |
| Spiriva | 17 | $13,092 | $770 |
| Stiolto Respimat | 21 | $12,797 | $609 |
| Combivent Respimat | 15 | $10,198 | $680 |
| Azelastine | 93 | $9,165 | $99 |
| Montelukast | 390 | $8,747 | $22 |
| Arnuity Ellipta | 22 | $8,211 | $373 |
| Trelegy Ellipta | 11 | $6,028 | $548 |
| Pulmicort Flexhaler | 12 | $5,031 | $419 |
| Zafirlukast | 33 | $4,938 | $150 |
| Qnasl | 19 | $4,621 | $243 |
| Clarithromycin Er | 42 | $4,432 | $106 |
| Tudorza Pressair | 13 | $4,174 | $321 |
| Omnaris | 11 | $3,258 | $296 |
| Azithromycin | 104 | $2,773 | $27 |
| Esomeprazole Magnesium | 21 | $2,641 | $126 |
| Accolate | 11 | $2,431 | $221 |
| Mometasone Furoate | 12 | $2,151 | $179 |
| Amoxicillin-Clavulanate Potass | 85 | $2,107 | $25 |
| Doxycycline Hyclate | 73 | $1,908 | $26 |
| Ipratropium | 31 | $1,238 | $40 |
| Ventolin Hfa | 18 | $1,092 | $61 |
| Ciprofloxacin | 38 | $1,012 | $27 |
| Oseltamivir Phosphate | 11 | $916 | $83 |
| Cefuroxime | 15 | $697 | $46 |
| Potassium Chloride | 13 | $570 | $44 |
| Pantoprazole | 22 | $512 | $23 |
| Levofloxacin | 22 | $426 | $19 |
| Fluticasone Propionate | 21 | $404 | $19 |
| Doxycycline Monohydrate | 13 | $362 | $28 |
| Atorvastatin | 16 | $352 | $22 |
| Zolpidem | 20 | $272 | $14 |
| Lorazepam | 30 | $260 | $9 |
| Prednisone | 21 | $247 | $12 |
| Levothyroxine | 16 | $208 | $13 |
| Oxycodone-Acetaminophen | 11 | $156 | $14 |
| Levocetirizine Dihydrochloride | 13 | $38 | $3 |
| Diazepam | 12 | $36 | $3 |
| Citalopram Hbr | 15 | $28 | $2 |
2017: 46 drugs
| Symbicort | 156 | $80,413 | $515 |
| Breo Ellipta | 98 | $67,033 | $684 |
| Dulera | 52 | $29,348 | $564 |
| Advair Diskus | 46 | $26,200 | $570 |
| Flovent Hfa | 39 | $25,103 | $644 |
| Spiriva | 31 | $23,236 | $750 |
| Incruse Ellipta | 46 | $21,040 | $457 |
| Anoro Ellipta | 19 | $18,147 | $955 |
| Spiriva Respimat | 19 | $16,548 | $871 |
| Azelastine | 101 | $9,528 | $94 |
| Qvar | 21 | $8,328 | $397 |
| Atrovent Hfa | 14 | $8,255 | $590 |
| Montelukast | 379 | $7,197 | $19 |
| Tudorza Pressair | 15 | $7,069 | $471 |
| Combivent Respimat | 12 | $6,039 | $503 |
| Zafirlukast | 38 | $5,929 | $156 |
| Qnasl | 22 | $5,868 | $267 |
| Arnuity Ellipta | 14 | $4,820 | $344 |
| Pulmicort Flexhaler | 13 | $4,773 | $367 |
| Doxycycline Hyclate | 76 | $3,981 | $52 |
| Omnaris | 16 | $3,674 | $230 |
| Clarithromycin Er | 27 | $3,285 | $122 |
| Azithromycin | 156 | $3,157 | $20 |
| Diovan Hct | 12 | $3,029 | $252 |
| Amoxicillin-Clavulanate Pot Er | 12 | $2,865 | $239 |
| Mometasone Furoate | 13 | $2,218 | $171 |
| Esomeprazole Magnesium | 15 | $2,125 | $142 |
| Amoxicillin-Clavulanate Potass | 84 | $2,104 | $25 |
| Proair Hfa | 15 | $1,742 | $116 |
| Ciprofloxacin | 38 | $934 | $25 |
| Pantoprazole | 31 | $637 | $21 |
| Levofloxacin | 28 | $627 | $22 |
| Ipratropium | 17 | $602 | $35 |
| Potassium Chloride | 17 | $592 | $35 |
| Zolpidem | 20 | $400 | $20 |
| Lorazepam | 24 | $366 | $15 |
| Doxycycline Monohydrate | 13 | $327 | $25 |
| Levothyroxine | 15 | $279 | $19 |
| Prednisone | 18 | $260 | $14 |
| Atorvastatin | 13 | $259 | $20 |
| Fluticasone Propionate | 11 | $247 | $22 |
| Sulfamethoxazole-Trimethoprim | 20 | $144 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $120 | $10 |
| Glipizide | 11 | $61 | $6 |
| Levocetirizine Dihydrochloride | 14 | $38 | $3 |
| Citalopram Hbr | 16 | $31 | $2 |
2016: 46 drugs
| Breo Ellipta | 139 | $66,118 | $476 |
| Symbicort | 102 | $43,684 | $428 |
| Dulera | 74 | $32,013 | $433 |
| Spiriva | 42 | $27,697 | $659 |
| Advair Diskus | 49 | $25,796 | $526 |
| Qvar | 49 | $16,200 | $331 |
| Spiriva Respimat | 23 | $13,403 | $583 |
| Tudorza Pressair | 25 | $11,677 | $467 |
| Omnaris | 40 | $11,264 | $282 |
| Flovent Hfa | 12 | $11,142 | $929 |
| Montelukast | 380 | $10,996 | $29 |
| Incruse Ellipta | 24 | $10,220 | $426 |
| Azelastine | 83 | $8,955 | $108 |
| Advair Hfa | 15 | $8,029 | $535 |
| Alvesco | 14 | $7,209 | $515 |
| Anoro Ellipta | 16 | $6,856 | $428 |
| Atrovent Hfa | 14 | $6,800 | $486 |
| Dymista | 20 | $6,168 | $308 |
| Qnasl | 29 | $6,087 | $210 |
| Amoxicillin-Clavulanate Pot Er | 31 | $5,851 | $189 |
| Mometasone Furoate | 29 | $5,682 | $196 |
| Nexium | 18 | $5,582 | $310 |
| Doxycycline Hyclate | 63 | $5,525 | $88 |
| Moxifloxacin | 16 | $4,878 | $305 |
| Combivent Respimat | 12 | $4,364 | $364 |
| Xopenex Hfa | 25 | $4,254 | $170 |
| Azithromycin | 130 | $4,065 | $31 |
| Zafirlukast | 31 | $4,047 | $131 |
| Clarithromycin Er | 35 | $3,584 | $102 |
| Diovan Hct | 12 | $2,566 | $214 |
| Amoxicillin-Clavulanate Potass | 23 | $2,305 | $100 |
| Proair Hfa | 32 | $2,226 | $70 |
| Ciprofloxacin | 60 | $1,962 | $33 |
| Ventolin Hfa | 23 | $1,664 | $72 |
| Prednisone | 35 | $701 | $20 |
| Pantoprazole | 37 | $643 | $17 |
| Potassium Chloride | 16 | $618 | $39 |
| Ipratropium | 28 | $601 | $21 |
| Levofloxacin | 14 | $558 | $40 |
| Levocetirizine Dihydrochloride | 18 | $553 | $31 |
| Zolpidem | 16 | $441 | $28 |
| Lorazepam | 30 | $410 | $14 |
| Fluticasone Propionate | 26 | $374 | $14 |
| Fluconazole | 15 | $344 | $23 |
| Sulfamethoxazole-Trimethoprim | 15 | $202 | $13 |
| Triamterene-Hydrochlorothiazid | 11 | $88 | $8 |
2015: 46 drugs
| Breo Ellipta | 108 | $41,283 | $382 |
| Symbicort | 91 | $40,844 | $449 |
| Advair Diskus | 54 | $27,262 | $505 |
| Spiriva | 45 | $22,476 | $499 |
| Dulera | 59 | $21,083 | $357 |
| Qvar | 50 | $18,980 | $380 |
| Tudorza Pressair | 47 | $17,239 | $367 |
| Flovent Hfa | 18 | $16,137 | $896 |
| Advair Hfa | 26 | $12,029 | $463 |
| Omnaris | 53 | $11,297 | $213 |
| Montelukast | 432 | $10,550 | $24 |
| Amoxicillin-Clavulanate Pot Er | 56 | $10,103 | $180 |
| Atrovent Hfa | 21 | $9,621 | $458 |
| Doxycycline Hyclate | 78 | $9,276 | $119 |
| Dymista | 27 | $9,198 | $341 |
| Azelastine | 83 | $9,121 | $110 |
| Nexium | 13 | $7,316 | $563 |
| Foradil | 25 | $6,802 | $272 |
| Serevent Diskus | 13 | $6,597 | $507 |
| Clarithromycin Er | 40 | $6,198 | $155 |
| Combivent Respimat | 16 | $5,688 | $355 |
| Qnasl | 29 | $5,030 | $173 |
| Nasonex | 22 | $5,003 | $227 |
| Azithromycin | 160 | $4,268 | $27 |
| Accolate | 17 | $3,543 | $208 |
| Zafirlukast | 15 | $3,356 | $224 |
| Xopenex Hfa | 20 | $3,163 | $158 |
| Diovan Hct | 12 | $2,249 | $187 |
| Proair Hfa | 23 | $1,656 | $72 |
| Rabeprazole | 11 | $1,512 | $137 |
| Ipratropium | 18 | $1,370 | $76 |
| Ciprofloxacin | 47 | $996 | $21 |
| Levocetirizine Dihydrochloride | 20 | $964 | $48 |
| Levofloxacin | 33 | $590 | $18 |
| Potassium Chloride | 16 | $536 | $33 |
| Fluticasone Propionate | 24 | $487 | $20 |
| Prednisone | 33 | $445 | $13 |
| Pantoprazole | 30 | $441 | $15 |
| Amoxicillin-Clavulanate Potass | 19 | $324 | $17 |
| Hydrocodone-Acetaminophen | 15 | $313 | $21 |
| Fluconazole | 11 | $238 | $22 |
| Atorvastatin | 13 | $203 | $16 |
| Lorazepam | 19 | $167 | $9 |
| Simvastatin | 11 | $139 | $13 |
| Triamterene-Hydrochlorothiazid | 13 | $131 | $10 |
| Sertraline | 11 | $42 | $4 |
2014: 42 drugs
| Symbicort | 112 | $41,560 | $371 |
| Advair Diskus | 72 | $37,983 | $528 |
| Spiriva | 61 | $31,101 | $510 |
| Flovent Hfa | 14 | $18,974 | $1,355 |
| Dulera | 50 | $16,561 | $331 |
| Advair Hfa | 32 | $16,478 | $515 |
| Montelukast | 380 | $15,986 | $42 |
| Qvar | 54 | $15,713 | $291 |
| Tudorza Pressair | 49 | $15,523 | $317 |
| Atrovent Hfa | 35 | $13,777 | $394 |
| Nexium | 15 | $12,871 | $858 |
| Breo Ellipta | 35 | $10,926 | $312 |
| Doxycycline Hyclate | 52 | $10,775 | $207 |
| Omnaris | 60 | $10,722 | $179 |
| Dymista | 26 | $8,159 | $314 |
| Asmanex | 21 | $8,013 | $382 |
| Astepro | 36 | $7,387 | $205 |
| Azelastine | 53 | $7,320 | $138 |
| Amoxicillin-Clavulanate Er | 38 | $6,676 | $176 |
| Clarithromycin Er | 43 | $6,638 | $154 |
| Foradil | 25 | $6,153 | $246 |
| Combivent Respimat | 18 | $4,913 | $273 |
| Zetonna | 14 | $4,584 | $327 |
| Azithromycin | 151 | $4,457 | $30 |
| Xopenex Hfa | 20 | $3,307 | $165 |
| Zafirlukast | 14 | $3,289 | $235 |
| Qnasl | 13 | $1,762 | $136 |
| Ipratropium | 17 | $1,598 | $94 |
| Proair Hfa | 28 | $1,473 | $53 |
| Ciprofloxacin | 52 | $849 | $16 |
| Nifedipine | 11 | $795 | $72 |
| Synthroid | 13 | $634 | $49 |
| Fluticasone Propionate | 29 | $610 | $21 |
| Omeprazole | 14 | $462 | $33 |
| Prednisone | 25 | $370 | $15 |
| Levofloxacin | 15 | $370 | $25 |
| Pantoprazole | 13 | $356 | $27 |
| Amox Tr-Potassium Clavulanate | 11 | $346 | $31 |
| Zolpidem | 23 | $216 | $9 |
| Acetaminophen-Codeine | 13 | $163 | $13 |
| Tramadol | 11 | $62 | $6 |
| Amoxicillin | 15 | $51 | $3 |
2013: 44 drugs
| Advair Diskus | 99 | $46,177 | $466 |
| Symbicort | 132 | $39,690 | $301 |
| Spiriva | 80 | $35,996 | $450 |
| Montelukast | 407 | $23,827 | $59 |
| Advair Hfa | 43 | $17,862 | $415 |
| Flovent Hfa | 18 | $17,267 | $959 |
| Qvar | 52 | $16,950 | $326 |
| Astepro | 89 | $16,357 | $184 |
| Dulera | 40 | $15,113 | $378 |
| Nexium | 20 | $11,718 | $586 |
| Atrovent Hfa | 27 | $11,678 | $433 |
| Tudorza Pressair | 44 | $11,470 | $261 |
| Amoxicillin-Clavulanate Er | 41 | $7,938 | $194 |
| Azithromycin | 214 | $7,700 | $36 |
| Doxycycline Hyclate | 45 | $7,500 | $167 |
| Dymista | 27 | $7,161 | $265 |
| Omnaris | 47 | $7,110 | $151 |
| Asmanex | 26 | $7,043 | $271 |
| Clarithromycin Er | 36 | $6,100 | $169 |
| Avelox | 12 | $5,371 | $448 |
| Nasonex | 13 | $4,293 | $330 |
| Foradil | 15 | $3,546 | $236 |
| Zetonna | 18 | $3,432 | $191 |
| Arcapta Neohaler | 13 | $2,635 | $203 |
| Zafirlukast | 11 | $2,608 | $237 |
| Azelastine | 17 | $1,983 | $117 |
| Xopenex Hfa | 20 | $1,940 | $97 |
| Fluticasone Propionate | 30 | $1,934 | $64 |
| Benicar | 15 | $1,906 | $127 |
| Proventil Hfa | 18 | $1,768 | $98 |
| Qnasl | 13 | $1,573 | $121 |
| Ipratropium | 16 | $1,131 | $71 |
| Nifedipine | 13 | $898 | $69 |
| Synthroid | 21 | $816 | $39 |
| Levocetirizine Dihydrochloride | 15 | $791 | $53 |
| Ciprofloxacin | 34 | $649 | $19 |
| Levofloxacin | 25 | $572 | $23 |
| Losartan | 13 | $334 | $26 |
| Hydrocodone-Acetaminophen | 25 | $326 | $13 |
| Cefuroxime | 12 | $322 | $27 |
| Prednisone | 29 | $251 | $9 |
| Tramadol | 33 | $157 | $5 |
| Zolpidem | 20 | $118 | $6 |
| Lorazepam | 11 | $80 | $7 |
Money from drug and device companies
$33 in 2024
| 2024 | 1 | 1 | None | $33 |
| 2023 | 1 | 3 | None | $76 |
| 2022 | 1 | 5 | None | $77 |
| 2021 | 1 | 5 | None | $84 |
| 2020 | 1 | 4 | None | $58 |
| 2019 | 1 | 1 | $20 | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merz North America | Xeomin | $33 | 1 payment
|
See the published payment
| Merz North America | Meals · 2024-01-24 | Xeomin | $33 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $76
| GlaxoSmithKline | Trelegy Ellipta | $76 | 3 payments
|
2022: $77
| GlaxoSmithKline | Trelegy Ellipta | $77 | 5 payments
|
2021: $84
| GlaxoSmithKline | Anoro Ellipta | $84 | 5 payments
|
2020: $58
| GlaxoSmithKline | Anoro Ellipta | $58 | 4 payments
|
2019: $20
| Boston Scientific | General Biliary Devices | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962575944
- Licence
- CA G32075California G32075: Current · expires 2028-07-31
- Trained
- Yale University School of Medicine, 1975
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RS0010X (207RS0010X); Federal specialty code 2083P0011X (2083P0011X)
- Mailing address
- 3351 El Camino Real Ste 200, Atherton, CA, 94027
- NPI first listed
- 2006-11-16
- NPI last updated
- 2021-04-02
- NPI record certified
- 2021-04-02
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.